What is the main business of SN Biotech Technologies sp. z o.o. sp.k.?

The main business activity of SN Biotech Technologies sp. z o.o. sp.k. focuses on other research and experimental development on natural sciences and engineering.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on June 9, 2008.

Where is the headquarters located?

The headquarters is located at: Krzemowa 1, 62-002 Złotniki.

What is the share capital?

The share capital of the company is PLN 12,625 (approx. $3,410).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

What revenue was generated?

In 2024, the company generated total revenue of $112,501, representing a decrease of 55.8% compared to 2023.

No, in 2024 the company reported a net loss of $7,829.

Which cost dominates operating expenses?

The largest operating cost category falls under other operating costs. This category amounted to $110,452 in 2024, representing 99% of all operating expenses.

SN Biotech Technologiessp. z o.o. + limited partnership

Other research and experimental development on natural sciences and engineering

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2008-06-09

Limited partner contribution

12,625.00 PLN

Activity description

SN Biotech Technologies is a research and development company in life sciences and agrochemical technologies, providing external R&D services to phytopharmaceutical companies. It develops and patents novel formulations of crop protection products and offers them to manufacturers at an early stage of development.

Registered address

Krzemowa 1, 62-002 Złotniki, Poland

Website

snbiotech.com

Financials

Revenue history (in k)

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 75 days late).

202509/07/2026
202411/07/2025
202309/07/2024
202205/07/2023
202128/09/2022
201928/09/2020

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 144.86kMedianUSD 73.26kAverageUSD 3.23m

Net profit

This companyUSD 54.37kMedianUSD 68.58AverageUSD 82.17k

Operating costs

This companyUSD 89.49kMedianUSD 75.78kAverageUSD 3.04m

Assets

This companyUSD 310.59kMedianUSD 119.88kAverageUSD 3.90m

Industry

Partners

Partners
Barbara Łucja Niechciałkowskaage 54
Krzysztof Niechciałkowskiage 58
Maciej Sipage 61
SN Biotech Technologies sp. z o.o.

Manner of representation

General partner independently

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2008-07-02.

Erste Bank Polska
07 1090 1463 0000 0001 0961 3882

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
Active Textsp. z o.o.	$409,418.80	active-text.pl
Medicofarma BiotechS.A.	$314,882.33	medicofarmabiotech.pl
FcbiotechS.A.	$246,877.92	fcbiotech.pl
Frontline BiosciencesS.A.	$219,186.29	frontlinebiosciences.com
TCIsp. z o.o.	$218,471.87	tci.pl
Nexbiosp. z o.o.	$186,582.40	nexbio.pl
BiottsS.A.	$159,262.71	biotts.com
Microbe Plussp. z o.o.	$104,197.26	microbe-plus.com
Bioaidsp. z o.o.	$94,146.77	bioaid.pl
Sfpesp. z o.o.	$72,850.26	sfpe.co.pl

Change history

Date	Event
2017-06-01	PKD change (Removed: 27 codes)
2008-10-28	Address change (Bukowska 12, 60-810, Poznań → Krzemowa 1, 62-002, Złotniki)
2008-06-09	Entered in the register

FAQ

Last updated: 2026-07-15